Company Overview and News

 
FCEL / FuelCell Energy, Inc. / LEVIN CAPITAL STRATEGIES, L.P. - null (Passive Investment)

2018-05-21 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* FUELCELL ENERGY, INC. ------------------------------------------------------ (NAME OF ISSUER) Common Stock, $0.0001 par value per share ------------------------------------------------------ (TITLE OF CLASS OF SECURITIES) 35952H502 -------

 
FCEL / FuelCell Energy, Inc. / LEVIN CAPITAL STRATEGIES, L.P. - null (Passive Investment)

2018-05-21 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* FUELCELL ENERGY, INC. ------------------------------------------------------ (NAME OF ISSUER) Common Stock, $0.0001 par value per share ------------------------------------------------------ (TITLE OF CLASS OF SECURITIES) 35952H502 -------

1
FCEL / FuelCell Energy, Inc. / LEVIN CAPITAL STRATEGIES, L.P. - null (Passive Investment)

2018-05-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* FUELCELL ENERGY, INC. ------------------------------------------------------ (NAME OF ISSUER) Common Stock, $0.0001 par value per share ------------------------------------------------------ (TITLE OF CLASS OF SECURITIES) 35952H502 -----------

4
FCEL / FuelCell Energy, Inc. / LEVIN CAPITAL STRATEGIES, L.P. - null (Passive Investment)

2018-05-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* FUELCELL ENERGY, INC. ------------------------------------------------------ (NAME OF ISSUER) Common Stock, $0.0001 par value per share ------------------------------------------------------ (TITLE OF CLASS OF SECURITIES) 35952H502 -----------

 
Short Sellers Getting Out of Solar, Alt Energy Stocks

2018-05-10 247wallst
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on April 30. Of the companies we watch, short interest fell on two of three solar stocks and fell on three of four alternative energy stocks.

 
FuelCell Energy Applauds the Passage of Senate Bill 9 in Connecticut

2018-05-09 globenewswire
DANBURY, Conn., May 09, 2018 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, applauds the passage of Senate Bill 9, An Act Concerning Connecticut’s Energy Future. This bill includes several key provisions and amendments important to the vitality of the fuel cell industry in Connecticut.

1
Legislators and Danbury-Based FuelCell Energy Call for Legislature and Governor to Support the Industry via Passage of Amendment to Senate Bill 9

2018-05-04 globenewswire
DANBURY, Conn., May 04, 2018 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, this morning at an 11:00 AM press conference at the State Capitol in Hartford, leaders of Danbury-based FuelCell Energy (FCE), joined by State Representatives Michelle Cook of Torrington, David Arconti of Danbury, and Tom Delnicki of South Windsor, called upon legislators of both parties to support a legislative amendment that the company’s CEO, Chip Bottone, said is “our company, and the economy that depends on our industry.

 
Short Sellers Look for Direction in Solar, Alt Energy Stocks

2018-04-25 247wallst
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on April 13. Of the companies we watch, short interest fell on two of three solar stocks and fell on two of four alternative energy stocks.

 
Alternative Energy Sees Cost Cuts, Corporate Ventures

2018-04-13 zacks
The broad consensus on the man-made nature of climate change notwithstanding, policies of the current U.S. administration run counter to it and favorable to the coal industry. But not all is lost – as a big part of the corporate sector and many local governments remain committed to taking steps to ensure a cleaner energy environment.

 
Zacks Industry Outlook Highlights: SolarEdge, JinkoSolar, FuelCell and First Solar

2018-04-13 zacks
Chicago, IL – April 13, 2018 – Today, Zacks Equity Research discusses the Industrial Metals, including SolarEdge Technologies (SEDG - Free Report) , JinkoSolar Holding (JKS - Free Report) , FuelCell Energy (FCEL - Free Report) and First Solar (FSLR - Free Report) .

 
Alternative Energy Stock Outlook - April 2018

2018-04-12 zacks
There is broad global consensus that the overuse of fossil fuels, which emits hazardous carbon dioxide and has expedited the process of climate change. Realizing the need for a cleaner energy environment, consumers have rapidly increased the adoption of alternative energy sources, nay renewables, over the last decade.

2
Short Interest Lags in Solar, Alt Energy Stocks

2018-04-11 247wallst
Short interest among solar and alternative energy stocks largely declined during the two-week reporting period that ended on March 29. Of the companies we watch, short interest fell on two of three solar stocks and fell on three of four alternative energy stocks.

 
Time to Focus on FuelCell Energy (FCEL) for Strong Earnings Growth Potential

2018-04-09 zacks
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

4
FCEL / FuelCell Energy, Inc. 8-K (Current Report)

2018-04-06 sec.gov
fcel-8k_20180405.htm

 
FCEL / FuelCell Energy, Inc. FORM S-8

2018-04-05 sec.gov
As filed with the Securities and Exchange Commission on April 5, 2018 Registration No. 333-

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 35952H106